Skip to main content
. 2020 Apr 28;8(2):203. doi: 10.3390/vaccines8020203

Table 5.

Multivariate analysis for OS

MVA for Overall Survival (p < 0.0001)
Covariate b Exp (b) 95% CI of Exp (b) p
Liver 0.5512 1.7353 1.1824 to 2.5467 0.0051
Brain 0.4889 1.6306 1.0786 to 2.4650 0.0211
NSCLC vs. others −1.3823 0.251 0.1707 to 0.3691 <0.0001
ECOG PS 0.8449 2.3278 1.8642 to 2.9067 <0.0001

Table 5 shows that liver and brain metastases are independent predictors of poor OS regardless of histology (p = 0.0051 and p = 0.0211 respectively). Table 5 footnotes: MVA: multivariate analysis; OS: overall survival: NSCLC: non-small cell lung cancer; Eastern Cooperative Oncology Group (ECOG) performance status (PS). Significant p-value in bold.